Author: Reuters

(Reuters) – The U.S. Food and Drug Administration on Tuesday approved Japan-based Shionogi & Co Ltd’s treatment for low blood-platelet count or thrombocytopenia in patients with chronic liver disease. The...

By Carolyn Crist (Reuters Health) – Black and Latino men are twice as likely as white men to die during interactions with police, according to a new study. Police-involved fatalities in the U.S. average nearly three deaths...

By Linda Carroll (Reuters Health) – Measles outbreaks can be very costly to communities, a new report suggests. For example, the 2013 measles outbreak in New York City cost the city’s health department nearly...

ABUJA (Reuters) – Nigeria has recalled 2.4 million bottles of cough syrup containing codeine after national outrage earlier this year over endemic use of opioids. Nigeria imposed a ban on the production and import of...

(Reuters) – Indivior Plc notched a legal victory on Tuesday after a U.S. court reaffirmed that a generic rival could not re-launch cheaper versions of the British drugmaker’s best-selling opioid addiction treatment...

By Lisa Rapaport (Reuters Health) – Breastfeeding mothers who drink alcohol may be more likely to have children with cognitive problems than women who abstain while nursing, an Australian study suggests. For the study,...

(Reuters) – The U.S. Food and Drug Administration (FDA) on Monday approved Progenics Pharmaceuticals Inc’s treatment for two types of rare adrenal gland tumors, making it the first drug approved in the United States...

By Linda Carroll (Reuters Health) – How the media reports on suicides may impact whether others decide to kill themselves in the days following the original death, a study suggests. An international team of researchers...

By Linda Carroll (Reuters Health) – Meat allergies related to tick bites might be at the root of some unexplained severe, life-threatening allergic reactions, a new study suggests. Researchers poring through records from a...

TEL AVIV (Reuters) – Israel’s RedHill Biopharma said on Monday it had positive safety and efficacy results from a late-stage clinical trial with its treatment for Crohn’s disease called RHB-104. The study met...